Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

Extraordinary/ Special General Meeting:

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in interest of Substantial Shareholder-Acer Incorporated

General Announcement: Business Update for the First Quarter ended 30 June 2026

Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

INVESTOR ALERT: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

Suzano Reports Adjusted EBITDA of R$4.7 Billion in the Second Quarter of 2026

Rio Tinto welcomes agreement to secure long-term future of Tomago Aluminium

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: NOTIFICATION FROM DIRECTOR/CEO IN RESPECT OF INTERESTS IN SECURITIES